Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (581-590 of 1,066) with videos related to

Pageof 107
Sort By:
International Journal of Molecular Sciences|January 15, 2021
Circulating microRNA: The Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy, a Pilot StudySelene De Benedittis, Francesco Fortunato, Claudia Cava, et al.
Journal of Cellular Physiology|May 4, 2012
Dissecting Pin1 and phospho-pRb regulationFlavio Rizzolio, Isabella Caligiuri, Chiara Lucchetti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 4, 2005
Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosisGiuseppina Caligiuri, Emilie Groyer, Jamila Khallou-Laschet, et al.
Infection|September 21, 2018
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximabEmanuela Zappulo, Laura Ambra Nicolini, Carmen Di Grazia, et al.
Nature Genetics|December 26, 2001
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2Danilo Perrotti, Vincenzo Cesi, Rossana Trotta, et al.
Breast Cancer Research and Treatment|December 4, 2008
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumabAruna Mani, Julie Roda, Donn Young, et al.
Journal of Virological Methods|April 4, 2014
Discordances with HIV-1 RNA quantitative determinations by three commercial assays in Pointe Noire, Republic of CongoBianca Bruzzone, Francesca Bisio, Patrizia Caligiuri, et al.
AIDS Research and Human Retroviruses|May 14, 2015
Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project)Bianca Bruzzone, Francesco Saladini, Laura Sticchi, et al.
Science Immunology|March 10, 2023
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cellsShoubao Ma, Jingjing Han, Zhenlong Li, et al.
Leukemia|July 15, 2015
Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemiaI-K Park, B Mundy-Bosse, S P Whitman, et al.
Pageof 107

Showing results (581-590 of 1,066) with videos related to

Sort By:
Pageof 107
International Journal of Molecular Sciences|January 15, 2021
Circulating microRNA: The Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy, a Pilot StudySelene De Benedittis, Francesco Fortunato, Claudia Cava, et al.
Journal of Cellular Physiology|May 4, 2012
Dissecting Pin1 and phospho-pRb regulationFlavio Rizzolio, Isabella Caligiuri, Chiara Lucchetti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 4, 2005
Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosisGiuseppina Caligiuri, Emilie Groyer, Jamila Khallou-Laschet, et al.
Infection|September 21, 2018
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximabEmanuela Zappulo, Laura Ambra Nicolini, Carmen Di Grazia, et al.
Nature Genetics|December 26, 2001
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2Danilo Perrotti, Vincenzo Cesi, Rossana Trotta, et al.
Breast Cancer Research and Treatment|December 4, 2008
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumabAruna Mani, Julie Roda, Donn Young, et al.
Journal of Virological Methods|April 4, 2014
Discordances with HIV-1 RNA quantitative determinations by three commercial assays in Pointe Noire, Republic of CongoBianca Bruzzone, Francesca Bisio, Patrizia Caligiuri, et al.
AIDS Research and Human Retroviruses|May 14, 2015
Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project)Bianca Bruzzone, Francesco Saladini, Laura Sticchi, et al.
Science Immunology|March 10, 2023
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cellsShoubao Ma, Jingjing Han, Zhenlong Li, et al.
Leukemia|July 15, 2015
Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemiaI-K Park, B Mundy-Bosse, S P Whitman, et al.
Pageof 107